FDA places Atara’s Biothearapeutics’ cancer, autoimmune therapies on hold
The US drug regulator has put a clinical hold on Atara Biotherapeuticsâ T-cell therapies for cancer and autoimmune diseases after issues were observed.
Drugs
Health
Pharma
US drug regulator rejects Atara Biotherapeuticsâ rare cancer therapy
Atara Biotherapeuticsâ Ebvallotm therapy, for treating patients with a rare cancer that occurs after stem cell transplantation, got rejected by the US drug.